255 related articles for article (PubMed ID: 19241900)
1. Intrahepatic sarcomatoid cholangiocarcinoma: clinical analysis of seven cases during a 15-year period.
Tsou YK; Wu RC; Hung CF; Lee CS
Chang Gung Med J; 2008; 31(6):599-605. PubMed ID: 19241900
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of sarcomatous cholangiocarcinoma of the liver.
Shimada M; Takenaka K; Rikimaru T; Hamatsu T; Yamashita Y; Kajiyama K; Taguchi K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2000; 47(34):956-61. PubMed ID: 11020857
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and surgical treatment of hepatic hilar cholangiocarcinoma.
Yang WL; Zhang XC; Zhang DW; Tong BF
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):631-5. PubMed ID: 18086631
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
Chaudhary HB; Bhanot P; Logroño R
Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
[TBL] [Abstract][Full Text] [Related]
5. Sarcomatous cholangiocarcinoma.
Gupta K; Powari M; Dey P
Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
[No Abstract] [Full Text] [Related]
6. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.
Uenishi T; Kubo S; Yamazaki O; Yamada T; Sasaki Y; Nagano H; Monden M
J Hepatobiliary Pancreat Surg; 2008; 15(4):417-22. PubMed ID: 18670844
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
8. Significance of repeated resection for recurrent intrahepatic cholangiocarcinoma.
Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Yoshitomi H; Furukawa K; Mitsuhashi N; Takeuchi D; Takayashiki T; Suda K; Miyazaki M
Hepatogastroenterology; 2009; 56(89):1-5. PubMed ID: 19453018
[TBL] [Abstract][Full Text] [Related]
9. Lymphoepithelioma-like cholangiocarcinoma not associated with EBV.
Adachi S; Morimoto O; Kobayashi T
Pathol Int; 2008 Jan; 58(1):69-74. PubMed ID: 18067645
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic study of cholangiocarcinoma with superficial spread.
Igami T; Nagino M; Oda K; Nishio H; Ebata T; Yokoyama Y; Shimoyama Y
Ann Surg; 2009 Feb; 249(2):296-302. PubMed ID: 19212185
[TBL] [Abstract][Full Text] [Related]
11. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
12. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.
Tonouchi A; Ohtsuka M; Ito H; Kimura F; Shimizu H; Kato M; Nimura Y; Iwase K; Hiwasa T; Seki N; Takiguchi M; Miyazaki M
Am J Gastroenterol; 2006 Jul; 101(7):1601-10. PubMed ID: 16863567
[TBL] [Abstract][Full Text] [Related]
13. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
14. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.
Nanashima A; Sumida Y; Abo T; Oikawa M; Murakami G; Takeshita H; Fukuoka H; Hidaka S; Nagayasu T; Sakamoto I; Sawai T
J Surg Oncol; 2008 Dec; 98(7):535-9. PubMed ID: 18814285
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
Jiang BG; Sun LL; Yu WL; Tang ZH; Zong M; Zhang YJ
Cancer J; 2009; 15(3):257-61. PubMed ID: 19556914
[TBL] [Abstract][Full Text] [Related]
16. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
[TBL] [Abstract][Full Text] [Related]
17. Extended liver resection for intrahepatic cholangiocarcinoma: A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification.
Jonas S; Thelen A; Benckert C; Biskup W; Neumann U; Rudolph B; Lopez-Häänninen E; Neuhaus P
Ann Surg; 2009 Feb; 249(2):303-9. PubMed ID: 19212186
[TBL] [Abstract][Full Text] [Related]
18. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
20. Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years.
Kim DK; Kim BR; Jeong JS; Baek YH
World J Gastroenterol; 2019 Feb; 25(5):608-621. PubMed ID: 30774275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
